Breast Cancer Management in North Carolina: Updates for 2020 SPOC
Dr. Emily Ray, from the UNC Lineberger Breast Oncology group, will describe relevant updates in systemic therapy for breast cancers for health care providers throughout the state of North Carolina.
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.
Recognize the options for adjuvant therapy in early stage HER2+ breast cancer
Describe the role of genomic assays in determining adjuvant treatment for early stage hormone receptor-positive (HR+) breast cancer
Define the options for treating metastatic HER2+ breast cancer
Emily Ray, MD, MPH
Presenter Disclosure Information
Emily Ray, MD, MPH, has no relevant financial relationships with commercial interests as defined by the ACCME.
This Non-Credit Course does NOT have accreditation for continuing education credits.
The course offers only general participation certificates.
- 1.00 Participation
UNC Lineberger Cancer Network certificate of participation.
Tim Poe, Director of Telehealth